Douglas G. Evans - 28 May 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Reporting relationship: Director
Issuer ticker: TELA
Reported as of: 28 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 May 2025, 16:18:35 UTC
Prior SEC filing: 06 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Megan Smeykal, Attorney-in-fact

Filing notes and source

Key filing fact

Douglas G. Evans filed Form 4 for TELA Bio, Inc. (TELA) on 30 May 2025.

Key facts

This page summarizes Douglas G. Evans's Form 4 filing for TELA Bio, Inc. (TELA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 30 May 2025, 16:18.

Change

Previous filing in this sequence was filed on 06 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001225164 Primary reporting owner

EVANS DOUGLAS G

Relationship: Director
Address: C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN
Signature: /s/ Megan Smeykal, Attorney-in-fact
Signature date: 30 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Award

Transaction value: $0
Shares: +7,950
Change %: +76%
Price: $0.000000
Shares after: 18,470
Date: 28 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TELA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +11,700
Change %
Price: $0.000000
Shares after: 11,700
Date: 28 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,700
Exercise price: $1.39
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Footnote F2

The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.